Asahi Intecc Group Signs A Basic Agreement with Penumbra, Inc. for Exclusive Sales of Peripheral Vascular Thrombus Aspiration Device "Indigotm and Lightningtm System" in the Japanese Market by Its Consolidated Subsidiary, Asahi Intecc J-Sales, Inc
September 22, 2022 at 02:30 am
Share
Asahi Intecc Group announced that it has signed a basic agreement with Penumbra, Inc. (hereinafter referred to as "Penumbra"), for the exclusive sales of peripheral vascular thrombus aspiration device "IndigoTM and LightningTM system" in the Japanese market by its consolidated subsidiary, Asahi Intecc J-sales, Inc. Based on this agreement, the two companies will proceed with discussions and preparatory activities for the introduction of the system, aiming to reach a final agreement by mid-February 2023.
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Asahi Intecc Group Signs A Basic Agreement with Penumbra, Inc. for Exclusive Sales of Peripheral Vascular Thrombus Aspiration Device "Indigotm and Lightningtm System" in the Japanese Market by Its Consolidated Subsidiary, Asahi Intecc J-Sales, Inc